Celemics, Inc.

Publications

Celemics’ Publications

Questioning How to Define the” Ultra-High-Risk” Subgroup of Neuroblastoma Patients

  • Post category:Oncology

Folia Biologica

Questioning How to Define the” Ultra-High-Risk” Subgroup of Neuroblastoma Patients

Demir AB, Aktas S, Altun Z, Ercetin P, Aktas TC, Olgun N. Questioning How to Define the “Ultra-High-Risk” Subgroup of Neuroblastoma Patients. Folia Biol (Praha). 2021;67(1):1–9.